Clinical Trial Update: Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose anticoagulation with Argatroban and Enoxaparin during ECMO for pneumonia or heart failure; the study status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pneumonia

Drugs mentioned

• Argatroban (argatroban)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University Hospital Ostrava | Conditions: Pneumonia, Heart Failure | Phase 2 | Status: NOT_YET_RECRUITING